Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Royalty Pharma plc
< Previous
1
2
Next >
Royalty Pharma Reports First Quarter 2025 Results
May 08, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Second Quarter 2025 Dividend
April 21, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
April 17, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
April 08, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Upcoming Investor Day
March 27, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
February 27, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces R&D Funding Collaboration With Biogen
February 12, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Q4 and Full Year 2024 Results
February 11, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
January 29, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
January 28, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
January 10, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
January 10, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Dividend Increase
January 09, 2025
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
November 27, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
November 14, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
November 07, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
GERN
RPRX
Royalty Pharma Reports Third Quarter 2024 Results
November 06, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
November 04, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 16, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Fourth Quarter 2024 Dividend
October 11, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 03, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
ASND
RPRX
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
August 28, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Reports Second Quarter 2024 Results
August 08, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
July 24, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
July 19, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Declares Third Quarter 2024 Dividend
July 17, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 04, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
June 03, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
May 28, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
May 13, 2024
From
Royalty Pharma plc
Via
GlobeNewswire
Tickers
RPRX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
